Among those routine tests, the oral glucose tolerance test (OGTT) is used between 24 and 28 weeks of gestation for the diagnosis of gestational diabetes mellitus (GDM), and the vaginal fluid fetal fibronectin is used for the diagnosis of preterm birth before 34 weeks of gestation in symptomatic women (7, 8). This evidence concerns the gene FN1 and gestational diabetes.